𝔖 Bobbio Scriptorium
✦   LIBER   ✦

QSAR methods for the discovery of new inflammatory bowel disease drugs

✍ Scribed by García-Domenech, Ramón; Gálvez-Llompart, María; Zanni, Riccardo; Recio, María C; Gálvez, Jorge


Book ID
120477553
Publisher
Informa plc
Year
2013
Tongue
English
Weight
654 KB
Volume
8
Category
Article
ISSN
1746-0441

No coin nor oath required. For personal study only.


📜 SIMILAR VOLUMES


New proteomic approaches for biomarker d
✍ Giulia Roda; Alessandra Caponi; Marco Benevento; Paolo Nanni; Laura Mezzanotte; 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 101 KB 👁 1 views

There is an increasing interest in the discovery of new inflammatory bowel disease (IBD) biomarkers able to predict the future patterns of disease and to help in diagnosis, treatment, and prognosis. A biomarker is a substance that can be measured biologically and is associated with an increased risk

Therapeutic drug monitoring of biologics
✍ Jean-Frédéric Colombel; Brian G. Feagan; William J. Sandborn; Gert Van Assche; A 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 434 KB 👁 1 views

## Background: Although tumor necrosis factor (tnf) antagonists are effective for the treatment of crohn's disease and ulcerative colitis, lack and loss of clinical response is a clinical challenge. accordingly, the use of therapeutic drug monitoring has been proposed as a means to optimize treatme

Alternative drug delivery approaches for
✍ Yvette Meissner; Alf Lamprecht 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 457 KB 👁 1 views

This article shall give an overview on drug delivery systems for new therapeutic strategies in the treatment of inflammatory bowel disease. The various features of the different approaches allowing locally restricted drug delivery to the inflamed colon are discussed including the main physiological